ASCO: HPV Vaccination Positively Affecting More Than Just Cervical Cancer Risk
By Elana Gotkine HealthDay Reporter
THURSDAY, May 23, 2024 -- Human papillomavirus (HPV) vaccination is associated with reduced odds of several types of HPV-related cancers, not just cervical cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.
Jefferson DeKloe, from Thomas Jefferson University in Philadelphia, and colleagues conducted a retrospective cohort study involving patients aged 9 to 39 years attending medical encounters where any vaccine was administered between Jan. 1, 2010, and Dec. 31, 2023. Participants were categorized into those vaccinated for HPV at least five years prior and those with no history of HPV vaccination.
The researchers found that males vaccinated for HPV had reduced odds of HPV-related cancers (odds ratio, 0.46), which was mainly driven by a significant reduction in head and neck cancer (HNC; odds ratio, 0.44). Females vaccinated for HPV had significantly lower odds of cervical cancers and HPV-related cancers overall (odds ratios, 0.71 and 0.73, respectively). No significant difference was seen in the odds of HNC and vulvar/vaginal cancer for vaccinated females versus controls. The likelihood of developing high-grade squamous intraepithelial lesions and carcinoma in situ was reduced for vaccinated females (odds ratios, 0.44 and 0.422, respectively).
"This study adds to a growing body of evidence demonstrating decreased rates of HPV-related cancer among people who received the HPV vaccination," DeKloe said in a statement. "Identifying effective interventions that increase HPV-vaccination rates is critical in reducing undue cancer burden in the United States."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy
FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...
Health Care Spending Growth Projected to Outpace GDP to 2032
THURSDAY, June 13, 2024 -- Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published...
Generation X Experiencing Larger Per-Capita Increases in Cancer Incidence
WEDNESDAY, June 12, 2024 -- Generation X is experiencing larger per-capita increases in the incidence of cancers than Baby Boomers, according to a study published online June 10...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.